Compared to endometrial and ovarian cancer, CC has a higher rate of PD-L1, as up to 80% of squamous and around 65% of adenocarcinomas are PD-L1-positive, and CD8+ T cells express PD1 [18,19]. The gene discussed is CD274; the disease is adenocarcinoma.